The Wockhardt Group, formerly a prominent player in the pharmaceutical industry, is facing financial distress. With mounting debts and a struggling business, the group's substantial assets are now scheduled for https://fraserocfa041214.mpeblog.com/61005845/wockhardt-facing-liquidation-assets-on-the-market